Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy

Abstract

M agnetic resonance imaging (MRI) is a widely used diagnostic tool for breast imaging in daily practice, with its high sensitivity to detect primary, recurrent, and residual breast cancer. Breast MRI serves as a reliable problem-solving tool in case of inconclusive mammography and ultrasonography (US) findings. It can be used to monitor the results of neoadjuvant chemotherapy and it may also contribute to preoperative evaluation of known lesions. With increasing use of MRI, number of breast lesions visible only on MRI and need for MRI-guided breast biopsy have increased (1). Second-look US can also be used for re-evaluation of these lesions; because US-guided biopsy is an easier, cheaper, and faster method if these lesions are visible on second-look US. According to a recently published meta-analysis, lesion detection rates with second-look US are variable in the literature (22.6%-82.1%). Mass lesions and malignant lesions were more likely to be detected at second-look US; average detection rates were 66% for masses, 29% for non-mass-like enhancement (NME) (2, 3). However, focal or NME lesions, which are less detectable than masses on second-look US, require MRI-guided biopsy in the majority of cases. According to the MRI-guided biopsy series in the literature, approximately 25%-35% of these lesions are diagnosed as malignant (4-9).Within this context, the aim of the present study is to assess the effectiveness of MRI-guided 10 Gauge (G) vacuum-assisted breast biopsies (VABB) performed at our institution and to examine the relationship between lesion characteristics and histopathologic results. B R E A S T I MAG I N G O R I G I N A L A R T I C L E PURPOSEWe aimed to assess the effectiveness of magnetic resonance imaging (MRI)-guided vacuum-assisted breast biopsy (VABB), evaluate and compare the characteristics and histopathologic findings of lesions, and overview the follow-up results of benign lesions. METHODSMRI findings and histopathologic results of breast lesions biopsied by MRI-guided VABB between 2013 and 2016 were retrospectively analyzed. MRI findings closely related with malignancy were investigated in particular. Follow-up results of benign lesions were evaluated. RESULTSMRI-guided VABB was applied to 116 lesions of 112 women. Of the lesions, 75 (65%) were benign, while 41 (35%) were malignant. Segmental (94%), clustered (89%), and clustered ring (67%) nonmass-like enhancement patterns were found to be more related with malignancy. False-negative rate of MRI-guided VABB was 12%, underestimation rate was 21%. One of the 54 followed-up benign lesions had a malignant result. CONCLUSION MRI-guided VABB is a reliable method for the diagnosis of breast lesions that are positive only on MRI. Follow-up results show that cancer detection rate is low for radio-pathologically concordant lesions. Further multicenter studies with larger patient population are needed to elucidate these results.You may cite this article as: Taşkın F, Soyder A, Tanyeri A, Öztürk VS, Ünsal A. Lesion characteristics, histopathologic r...

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

“…The malignancy rate in this study of women with MRI-visible breast lesions who underwent MRI-guided wire localization with subsequent surgical biopsy and MRI-guided biopsy of breast minimal lesions was 40.91% (in 13 patients who underwent MRI-guided biopsy, the malignancy rate was 23.08%, and in 74 patients with 75 eligible lesions who underwent MRI-guided wire localization with surgical biopsy, the malignancy rate was 44.0%), which is higher than the reported range of 20-35% (22)(23)(24)(25). The main difference in this study was that the majority of patients (n = 74) underwent MRI-guided wire localization with subsequent surgical biopsy (the number of suspicious lesions was 75), and only 13 patients underwent MRI-guided biopsy.…”

Application value of MRI-guided wire localization to the non-palpable breast lesions only shown in Breast MRI

“…MRI-guided wire localization is an important intervention method, which is based on careful radiological analysis and accurate evaluation of BI-RADS Class 4 and above lesions. The overall malignant rate for MRI-guided wire localization ranges from 20% to 35% in European and American countries (21)(22)(23)(24). The malignant rate of MRI-guided biopsy was 43% in 185 women with high risk of breast cancer according to Miah et al in 2023 (25).…”

“…There was a statistical correlation between the enhancement pattern of lesions and the malignancy rate in the reports of Macura et al (32), Dratwa et al (33), and Moreno et al (34) involving 541 MRI biopsy cases; they found that it was difficult to assess whether the lesion was benign or malignant based on simple enhancing morphology (NME, EM, or EF); however, the early rapid inflow (p = 0.038) and delayed outflow hemodynamics (p = 0.032) of DCE-MRI were significantly correlated with malignancy. Myers et al's (21) research findings suggested that the malignant rate was related to the "outflow" of TIC. In this study, the statistical correlation of benign or malignant lesions involved hemodynamics (TIC curve), rather than the morphological enhancement (EF, EM, and NME).…”

MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management

“…As a result, widespread adoption of breast MRI in clinical practice has led to increased biopsy rates but diminished diagnostic yield (8). Recent studies have shown that the large majority (65-74%) of suspicious breast MRI lesions investigated with MRI-guided CNB are benign (65-74%) (16)(17)(18) with the most common pathologic diagnosis being FCC.…”